Takeda Pharmaceutical Co. Ltd. | Income Statement
Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
2019
Sales/Revenue
1,691,685
1,777,824
1,807,378
1,732,051
1,770,531
2,097,224
Cost of Goods Sold (COGS) incl. D&A
630,704
643,433
645,536
714,393
621,664
854,382
Gross Income
1,060,981
1,134,391
1,161,842
1,017,658
1,148,867
1,242,842
SG&A Expense
897,027
980,230
996,198
930,686
953,547
1,060,985
EBIT
145,604
195,804
172,035
-
195,320
181,857
Unusual Expense
32,894
338,913
44,974
55,679
115,885
125,887
Non Operating Income/Expense
48,660
5,159
4,612
122,049
179,418
144,115
Interest Expense
4,888
11,137
7,958
10,470
12,731
68,181
Pretax Income
158,851
145,437
120,542
143,346
217,205
94,896
Income Tax
49,293
2,403
37,060
27,833
30,497
14,118
Equity in Affiliates
-
-
3
-
-
-
Consolidated Net Income
109,558
143,034
83,479
115,513
186,708
109,014
Net Income
106,658
145,775
80,166
114,940
186,886
109,126
Net Income After Extraordinaries
106,658
145,775
80,166
114,940
186,886
109,126
Net Income Available to Common
106,658
145,775
80,166
114,940
186,886
109,126
EPS (Basic)
135.10
185.37
102.26
147.15
239.35
113.50
Basic Shares Outstanding
789
786
784
781
781
961
EPS (Diluted)
134.95
185.37
101.71
146.25
237.55
112.86
Diluted Shares Outstanding
790
786
788
786
787
967
EBITDA
332,856
387,391
353,275
258,398
377,447
454,303
Other Operating Expense
18,350
41,643
6,391
-
-
-
Non-Operating Interest Income
1,369
2,313
2,316
2,019
3,282
6,619
Minority Interest Expense
2,900
2,741
3,313
573
178
112
Equity in Affiliates (Pretax)
1,000
1,337
-
1,546
32,199
43,627
About Takeda Pharmaceutical Co.
View Profile
